Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens

Overview of attention for article published in PLOS ONE, September 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents

Cited by Centers for Disease Control and Prevention (CDC) on 14 Jul 2016

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents

Cited by Centers for Disease Control and Prevention (CDC) on 08 Apr 2015

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.